Spots Global Cancer Trial Database for Acupuncture in Myasthenia Gravis (AcuMG)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Acupuncture in Myasthenia Gravis (AcuMG)
Official Title: Acupuncture Treatment for Individuals With Myasthenia Gravis
Study ID: NCT05230082
Conditions
Interventions
Study Description
Brief Summary: The purpose of the study is to determine the effect acupuncture treatment on individuals with a diagnosis of Myasthenia Gravis (MG). A total of 20 people with MG will be enrolled in this study to receive acupuncture treatment 2 times a week for 12 weeks. Participants will be randomized into two groups: 1) Immediate start and 2) Delayed start (12 weeks). The delayed start group will act as a control group for the first 12 weeks, but then receive acupuncture treatment for 12 weeks. It is hypothesized that patients with MG who receive acupuncture treatment will have improved quality of life and activities of daily living compared to no treatment.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States
Contact Details
Name: Amanda A Herrmann, PhD
Affiliation: HealthPartners Neuroscience Research
Role: PRINCIPAL_INVESTIGATOR
Name: Gaurav K Guliani, MD
Affiliation: HealthPartners Neurology
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
